Sep 12, 2022 / 09:30AM GMT
Bruno Eschli - Roche Holding AG - Head of IR
So welcome to our Annual Pharma Day in London. I have to say it's a great pleasure to be here again on site and to meet all of you in person, and I'm looking forward to many lively debates and discussions, which we will have, and several opportunities during the event here with the investor and the analyst community.
However, I would go for the agenda and some housekeeping items. However, before we start, I would like to say the following. We, at Roche would like to extend our greatest condolences to all the people in the U.K. for the loss of Queen Elizabeth, and we are with you in these very special days.
Moving now to the first slide. Just taking you quickly through the agenda. Our event, as you can see here, will be kicked off by Bill Anderson, our CEO of the Pharmaceuticals division, who will provide his update on the ongoing business transformation, summarize past achievements, but most importantly, also outline our vision and show you -- to send to you the future building blocks, which we need for success as an R&D-driven company,
Roche Holding AG Pharma Day 2022 Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot